While the specific roles for PRA and PRB remain unclear in endometrial cancer, studies suggest that PRB may be the primary isoform responsible for the growth inhibitory and tumor suppressive actions of progesterone in vitro. This evidence concerns the gene RB1 and endometrial cancer.